VISA
8.11.2021 11:02:11 CET | Business Wire | Press release
As a result of a new global technology partnership between Daimler Mobility and Visa, Daimler will offer “native” in-car payments. This means that entering passwords or relying on mobile devices for payment authentication may soon be a thing of the past as the vehicle itself becomes a biometrically enabled payments device, thanks to Visa’s Delegated Authentication technology.
From spring 2022 onwards, Mercedes-Benz customers in the UK and Germany will be able to make payments using a fingerprint sensor in the car, with other European markets to follow. Purchases can then be made directly through the car’s head unit, or MBUX. The solution is anticipated to be available in other markets globally at a later stage.
In-car commerce has become an integral aspect of the luxury customer experience. For example, Daimler Mobility's global payment platform called Mercedes pay enables customers to buy goods and services directly in their car, including Mercedes me services, as well as for other use cases such as fuelling and parking.
Antony Cahill, Deputy CEO and Head of European Markets, at Visa in Europe:
"We are excited to bring to life a native solution for in-car payments for the first time, together with our partner Daimler Mobility. It is significant that both the successful pilot testing and initial launch activities are taking place in Europe, a world-leading hub for payments and automotive innovation. This is a powerful example of how the world’s leader in digital payments and the inventor of the automobile are able to combine their technologies to create the next generation of smart solutions for the automobility sector, providing the driver and passengers with a completely new in-car connected commerce experience.”
Franz Reiner, Chief Executive Officer, Daimler Mobility:
“Mercedes pay is our competence centre for in-car payment, through which we offer our customers worldwide digital services seamlessly integrated within the Mercedes-Benz ecosystem. In partnership with Visa, Daimler aims to offer native in-car payments that meet the requirements of two-factor authentication in a secure and user-friendly way. There is nothing more convenient than authorising a payment with your fingerprint. A luxury customer experience of course includes the aspect of safety, and we fulfil that through native in-car payment. We offer our customers security not only when driving, but also when paying.”
The technology behind native in-car digital commerce
Mercedes pay is a component of Daimler’s mobility and digitalization strategy, and a business segment of Daimler Mobility. Daimler will be the first ever automotive company in the world to incorporate the Visa Cloud Token Framework into its vehicles. Visa’s Cloud Token Framework is a cloud-based security technology that allows more flexibility across multiple devices as Visa Cloud Tokens protect and remove sensitive payment information by converting data and storing it securely. They also enable multiple device pairing in and beyond the car, which are then directly integrated with the consumer’s bank credentials. This significantly improves the overall payment experience as consumers no longer need to enter long card numbers to complete a purchase or switch between devices to authenticate payments. The solution will be used to initiate a two-factor authentication1 .
Promising future for in-car digital commerce
In the next two years alone, the number of connected cars is estimated to increase to more than 352 million worldwide2 and the total volume of in-car payments is set to reach approximately $86 billion by 20253 .
Mobility trends like electric vehicles, car sharing, autonomous driving and connected cars are increasing the demand for innovative payment methods within the vehicle itself. Today, when you buy car-related services, many require the motorist to use a separate device to log onto an app or website. Daimler and Visa’s ambition is to enable users to have a hassle-free payments experience through the car, while also expanding the choice and quality of experiences available to them.
Daimler Mobility at a Glance
In addition to Mercedes-Benz AG and Daimler Truck AG, Daimler Mobility AG is one of the three business divisions of Daimler AG. It has about 11,650 employees and specializes in financial and mobility solutions. Its products range from leasing, financing, and insurance products to innovative fleet management systems and app-based mobility services. As a financial services provider, the business division supports the sales of the Daimler Group’s automotive brands worldwide. In Germany, Mercedes-Benz Bank AG, part of the Daimler Mobility division, is one of the country’s leading automotive banks. It provides around one million customers with financial leeway as well as call-money and fixed-interest-rate accounts in the direct banking business. The product range is supplemented by flexible mobility services such as Mercedes-Benz Rent and EQ subscriptions, which enable an uncomplicated and flexible entry into electro mobility. Through its subsidiary Athlon, Daimler Mobility is represented in the commercial fleet management segment as well as in vehicle leasing in Europe. The company manages more than 400,000 vehicles in total. As a strategic investor, Daimler Mobility also participates in the business potential of digital mobility solutions through its holdings. The focus is on its involvement in FREE NOW, SHARE NOW and CHARGE NOW. These pillars combine ride-hailing, carsharing, multimodal mobility and the charging of electric vehicles. Daimler Mobility’s portfolio also contains holdings in the limousine ride-hailing service StarRides in China and the chauffeur service provider Blacklane. In 2020, Daimler Mobility financed or leased around 50 percent of the vehicles sold by Daimler worldwide. This corresponds to a contract volume of €150.6 billion. In 2020, the business division generated revenue of €27.7 billion and achieved EBIT of €1.4 billion. Daimler Mobility operates in 39 countries.
LinkedIn: https://www.linkedin.com/company/daimler-mobility
About Visa Inc.
Visa Inc. (NYSE: V) is the world’s leader in digital payments. Our mission is to connect the world through the most innovative, reliable and secure payment network - enabling individuals, businesses and economies to thrive. Our advanced global processing network, VisaNet, provides secure and reliable payments around the world, and is capable of handling more than 65,000 transaction messages a second. The company’s relentless focus on innovation is a catalyst for the rapid growth of digital commerce on any device for everyone, everywhere. As the world moves from analogue to digital, Visa is applying our brand, products, people, network and scale to reshape the future of commerce. For more information, visit About Visa , visa.com/blog and @VisaNews .
1 Strong Customer Authentication (SCA) compliance requires two-factor authentication consisting of the following: something the consumer knows (e.g. a password), possess (e.g. a connected device) or is (e.g. biometrics). Daimler Mobility makes use of Visa’s Delegated Authentication Service, making it possible to apply SCA on behalf of the issuer.
2 Capgemini Invent: Connected Vehicle Trend Radar 2 , 2020.
3 Juniper Research: The Race for In-Vehicle Payments , 2020.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211108005472/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
